Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Harnessing undomesticated life.

Libby EA, Silver PA.

Nat Microbiol. 2019 Feb;4(2):212-213. doi: 10.1038/s41564-018-0355-8. No abstract available.

PMID:
30675034
2.

Predicting mutational routes to new adaptive phenotypes.

Lind PA, Libby E, Herzog J, Rainey PB.

Elife. 2019 Jan 8;8. pii: e38822. doi: 10.7554/eLife.38822.

3.

Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial.

Budde LE, Wu D, Martin DB, Philip M, Shustov AR, Smith SD, Gooley TA, Chen TL, Libby EN, Chen EY, Kojouri K, Langerak A, Roden JE, Press OW, Gopal AK.

Br J Haematol. 2018 Nov;183(4):601-607. doi: 10.1111/bjh.15585. Epub 2018 Sep 14.

PMID:
30596402
4.

A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeks.

Poston JN, Fromm JR, Rasmussen HA, Shustov AR, Libby EN 3rd, Smith SD, Gooley T, Gopal AK.

Br J Haematol. 2018 Dec 28. doi: 10.1111/bjh.15742. [Epub ahead of print] No abstract available.

PMID:
30592026
5.

Metastatic inflammatory myofibroblastic tumor of the bladder.

Libby EK, Ellis LT, Weinstein S, Hammer RD, Murray KS.

Urol Case Rep. 2018 Nov 15;23:10-12. doi: 10.1016/j.eucr.2018.11.007. eCollection 2019 Mar.

6.

Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.

Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Anderson LD Jr, Sutherland HJ, Yong K, Hoos A, Gorczyca MM, Lahiri S, He Z, Austin DJ, Opalinska JB, Cohen AD.

Lancet Oncol. 2018 Dec;19(12):1641-1653. doi: 10.1016/S1470-2045(18)30576-X. Epub 2018 Nov 12.

PMID:
30442502
7.

Environmentally Mediated Social Dilemmas.

Estrela S, Libby E, Van Cleve J, Débarre F, Deforet M, Harcombe WR, Peña J, Brown SP, Hochberg ME.

Trends Ecol Evol. 2019 Jan;34(1):6-18. doi: 10.1016/j.tree.2018.10.004. Epub 2018 Nov 8. Review.

PMID:
30415827
8.

Triplet therapies - the new standard of care for multiple myeloma: how to manage common toxicities.

Paner A, Okwuosa TM, Richardson KJ, Libby EN.

Expert Rev Hematol. 2018 Oct 19. doi: 10.1080/17474086.2018.1538777. [Epub ahead of print]

PMID:
30339769
9.

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA; RELEVANCE Trial Investigators.

N Engl J Med. 2018 Sep 6;379(10):934-947. doi: 10.1056/NEJMoa1805104.

PMID:
30184451
10.

Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016.

Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP, Foreman K, Gupta R, Harvey J, Hosgood HD, Jakovljevic M, Khader Y, Linn S, Lad D, Mantovani L, Nong VM, Mokdad A, Naghavi M, Postma M, Roshandel G, Shackelford K, Sisay M, Nguyen CT, Tran TT, Xuan BT, Ukwaja KN, Vollset SE, Weiderpass E, Libby EN, Fitzmaurice C.

JAMA Oncol. 2018 Sep 1;4(9):1221-1227. doi: 10.1001/jamaoncol.2018.2128.

11.

Publisher Correction: Programmed cell death can increase the efficacy of microbial bet hedging.

Libby E, Driscoll WW, Ratcliff WC.

Sci Rep. 2018 Apr 19;8(1):6433. doi: 10.1038/s41598-018-23599-6.

12.

Plasma cell diseases and organ transplant: A comprehensive review.

Cowan AJ, Johnson CK, Libby EN.

Am J Transplant. 2018 May;18(5):1046-1058. doi: 10.1111/ajt.14731. Review.

PMID:
29524307
13.

Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.

Cowan AJ, Stevenson PA, Libby EN, Becker PS, Coffey DG, Green DJ, Hyun TS, Fromm JR, Gopal AK, Holmberg LA.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1386-1391. doi: 10.1016/j.bbmt.2018.02.017. Epub 2018 Mar 1.

PMID:
29481870
14.

Programmed cell death can increase the efficacy of microbial bet -hedging.

Libby E, Driscoll WW, Ratcliff WC.

Sci Rep. 2018 Jan 18;8(1):1120. doi: 10.1038/s41598-017-18687-y. Erratum in: Sci Rep. 2018 Apr 19;8(1):6433.

15.

Paradoxes in leaky microbial trade.

Kallus Y, Miller JH, Libby E.

Nat Commun. 2017 Nov 8;8(1):1361. doi: 10.1038/s41467-017-01628-8.

16.

Nascent life cycles and the emergence of higher-level individuality.

Ratcliff WC, Herron M, Conlin PL, Libby E.

Philos Trans R Soc Lond B Biol Sci. 2017 Dec 5;372(1735). pii: 20160420. doi: 10.1098/rstb.2016.0420.

17.

Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice.

Raju SV, Rasmussen L, Sloane PA, Tang LP, Libby EF, Rowe SM.

Respir Res. 2017 Sep 18;18(1):173. doi: 10.1186/s12931-017-0656-0.

18.

Strategic tradeoffs in competitor dynamics on adaptive networks.

Hébert-Dufresne L, Allard A, Noël PA, Young JG, Libby E.

Sci Rep. 2017 Aug 8;7(1):7576. doi: 10.1038/s41598-017-07621-x.

19.

Habits of Highly Effective Biofilms: Ion Signaling.

Libby EA, Dworkin J.

Mol Cell. 2017 Jun 15;66(6):733-734. doi: 10.1016/j.molcel.2017.05.036.

20.

Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells.

Tavera-Mendoza LE, Westerling T, Libby E, Marusyk A, Cato L, Cassani R, Cameron LA, Ficarro SB, Marto JA, Klawitter J, Brown M.

Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):E2186-E2194. doi: 10.1073/pnas.1615015114. Epub 2017 Feb 27.

21.

Drivers of Bacterial Maintenance and Minimal Energy Requirements.

Kempes CP, van Bodegom PM, Wolpert D, Libby E, Amend J, Hoehler T.

Front Microbiol. 2017 Jan 31;8:31. doi: 10.3389/fmicb.2017.00031. eCollection 2017.

22.

Pristine but metal-rich Río Sucio (Dirty River) is dominated by Gallionella and other iron-sulfur oxidizing microbes.

Arce-Rodríguez A, Puente-Sánchez F, Avendaño R, Libby E, Rojas L, Cambronero JC, Pieper DH, Timmis KN, Chavarría M.

Extremophiles. 2017 Mar;21(2):235-243. doi: 10.1007/s00792-016-0898-7. Epub 2016 Dec 8.

PMID:
27933457
23.

Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation.

Cowan AJ, Klippel ZK, Stevenson PA, Hyun TS, Tuazon S, Becker PS, Green DJ, Holmberg LA, Coffey DG, Gopal AK, Libby EN.

Amyloid. 2016 Dec;23(4):254-259. Epub 2016 Nov 23.

24.

SIN3A and SIN3B differentially regulate breast cancer metastasis.

Lewis MJ, Liu J, Libby EF, Lee M, Crawford NP, Hurst DR.

Oncotarget. 2016 Nov 29;7(48):78713-78725. doi: 10.18632/oncotarget.12805.

25.

Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation.

Mutyam V, Libby EF, Peng N, Hadjiliadis D, Bonk M, Solomon GM, Rowe SM.

J Cyst Fibros. 2017 Jan;16(1):24-29. doi: 10.1016/j.jcf.2016.09.005. Epub 2016 Oct 1.

26.

A ferret model of COPD-related chronic bronchitis.

Raju SV, Kim H, Byzek SA, Tang LP, Trombley JE, Jackson P, Rasmussen L, Wells JM, Libby EF, Dohm E, Winter L, Samuel SL, Zinn KR, Blalock JE, Schoeb TR, Dransfield MT, Rowe SM.

JCI Insight. 2016 Sep 22;1(15):e87536.

27.

Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial.

Yee AJ, Bensinger WI, Supko JG, Voorhees PM, Berdeja JG, Richardson PG, Libby EN, Wallace EE, Birrer NE, Burke JN, Tamang DL, Yang M, Jones SS, Wheeler CA, Markelewicz RJ, Raje NS.

Lancet Oncol. 2016 Nov;17(11):1569-1578. doi: 10.1016/S1470-2045(16)30375-8. Epub 2016 Sep 17.

PMID:
27646843
28.

Epigenetic inheritance systems contribute to the evolution of a germline.

Lachmann M, Libby E.

Philos Trans R Soc Lond B Biol Sci. 2016 Aug 19;371(1701). pii: 20150445. doi: 10.1098/rstb.2015.0445.

29.

Stabilizing multicellularity through ratcheting.

Libby E, Conlin PL, Kerr B, Ratcliff WC.

Philos Trans R Soc Lond B Biol Sci. 2016 Aug 19;371(1701). pii: 20150444. doi: 10.1098/rstb.2015.0444.

30.

Increased autophagic response in a population of metastatic breast cancer cells.

Li YI, Libby EF, Lewis MJ, Liu J, Shacka JJ, Hurst DR.

Oncol Lett. 2016 Jul;12(1):523-529. Epub 2016 May 24.

31.

In Vivo Probe of Lipid II-Interacting Proteins.

Sarkar S, Libby EA, Pidgeon SE, Dworkin J, Pires MM.

Angew Chem Int Ed Engl. 2016 Jul 11;55(29):8401-4. doi: 10.1002/anie.201603441. Epub 2016 May 25.

32.

A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).

Zent CS, Victoria Wang X, Ketterling RP, Hanson CA, Libby EN, Barrientos JC, Call TG, Chang JE, Liu JJ, Calvo AR, Lazarus HM, Rowe JM, Luger SM, Litzow MR, Tallman MS.

Am J Hematol. 2016 Mar;91(3):308-12. doi: 10.1002/ajh.24265. Epub 2016 Feb 9.

33.

High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.

Cassaday RD, Stevenson PA, Gooley TA, Chauncey TR, Pagel JM, Rajendran J, Till BG, Philip M, Orozco JJ, Bensinger WI, Holmberg LA, Shustov AR, Green DJ, Smith SD, Libby EN, Maloney DG, Press OW, Gopal AK.

Br J Haematol. 2015 Dec;171(5):788-97. doi: 10.1111/bjh.13773. Epub 2015 Oct 12.

34.

Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.

Cowan AJ, Stevenson PA, Cassaday RD, Graf SA, Fromm JR, Wu D, Holmberg LA, Till BG, Chauncey TR, Smith SD, Philip M, Orozco JJ, Shustov AR, Green DJ, Libby EN 3rd, Bensinger WI, Shadman M, Maloney DG, Press OW, Gopal AK.

Biol Blood Marrow Transplant. 2016 Feb;22(2):380-385. doi: 10.1016/j.bbmt.2015.08.035. Epub 2015 Sep 5.

35.

Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma.

Graf SA, Stevenson PA, Holmberg LA, Till BG, Press OW, Chauncey TR, Smith SD, Philip M, Orozco JJ, Shustov AR, Green DJ, Libby EN 3rd, Bensinger WI, Pagel JM, Maloney DG, Zhou Y, Cassaday RD, Gopal AK.

Ann Oncol. 2015 Nov;26(11):2323-8. doi: 10.1093/annonc/mdv364. Epub 2015 Sep 7.

36.

The Eukaryotic-Like Ser/Thr Kinase PrkC Regulates the Essential WalRK Two-Component System in Bacillus subtilis.

Libby EA, Goss LA, Dworkin J.

PLoS Genet. 2015 Jun 23;11(6):e1005275. doi: 10.1371/journal.pgen.1005275. eCollection 2015 Jun.

37.

Bistability in a metabolic network underpins the de novo evolution of colony switching in Pseudomonas fluorescens.

Gallie J, Libby E, Bertels F, Remigi P, Jendresen CB, Ferguson GC, Desprat N, Buffing MF, Sauer U, Beaumont HJ, Martinussen J, Kilstrup M, Rainey PB.

PLoS Biol. 2015 Mar 12;13(3):e1002109. doi: 10.1371/journal.pbio.1002109. eCollection 2015 Mar.

38.

Utilization of stored autologous PBSCs to support second autologous transplantation in multiple myeloma patients in the era of novel agent therapy.

Phipps C, Linenberger M, Holmberg LA, Green D, Becker P, Connelly-Smith L, Klippel Z, Burwick N, Gopal A, Bensinger WI, Libby E.

Bone Marrow Transplant. 2015 May;50(5):663-7. doi: 10.1038/bmt.2015.13. Epub 2015 Mar 2.

PMID:
25730190
39.

Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma.

Mikhael JR, Reeder CB, Libby EN, Costa LJ, Bergsagel PL, Buadi F, Mayo A, Nagi Reddy SK, Gano K, Dueck AC, Stewart AK.

Br J Haematol. 2015 Apr;169(2):219-27. doi: 10.1111/bjh.13296. Epub 2015 Feb 13.

40.

Courting disaster: How diversification rate affects fitness under risk.

Ratcliff WC, Hawthorne P, Libby E.

Evolution. 2015 Jan;69(1):126-35. doi: 10.1111/evo.12568. Epub 2014 Dec 23.

41.

Panobinostat: a review of trial results and future prospects in multiple myeloma.

Libby EN, Becker PS, Burwick N, Green DJ, Holmberg L, Bensinger WI.

Expert Rev Hematol. 2015 Feb;8(1):9-18. doi: 10.1586/17474086.2015.983065. Epub 2014 Nov 20. Review.

PMID:
25410127
42.

Evolution. Ratcheting the evolution of multicellularity.

Libby E, Ratcliff WC.

Science. 2014 Oct 24;346(6208):426-7. doi: 10.1126/science.1262053. No abstract available.

PMID:
25342789
43.

Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status.

Onishi M, Graf SA, Holmberg L, Behnia S, Shustov AR, Schiavo K, Philip M, Libby EN, Cassaday RD, Pagel JM, Roden JE, Maloney DG, Green DJ, Till BG, Press OW, Smith SD, Gopal AK.

Hematol Oncol. 2015 Dec;33(4):187-91. doi: 10.1002/hon.2166. Epub 2014 Sep 18.

44.

Geometry shapes evolution of early multicellularity.

Libby E, Ratcliff W, Travisano M, Kerr B.

PLoS Comput Biol. 2014 Sep 18;10(9):e1003803. doi: 10.1371/journal.pcbi.1003803. eCollection 2014 Sep.

45.

Linking adiponectin and autophagy in the regulation of breast cancer metastasis.

Libby EF, Frost AR, Demark-Wahnefried W, Hurst DR.

J Mol Med (Berl). 2014 Oct;92(10):1015-23. doi: 10.1007/s00109-014-1179-5. Epub 2014 Jun 7. Review.

46.

Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity.

Phipps C, Gopal AK, Storer BE, Cassaday RD, Press OW, Till BG, Pagel JM, Palanca-Wessels MC, Philip M, Bensinger WI, Holmberg LA, Shustov AR, Green DJ, Chauncey T, Maloney DG, Libby EN 3rd.

Leuk Lymphoma. 2015 Jan;56(1):92-6. doi: 10.3109/10428194.2014.911866. Epub 2014 Jun 17.

47.

Obesity is associated with higher 4E-BP1 expression in endometrial cancer.

Libby EF, Azrad M, Novak L, Vazquez AI, Wilson TR, Demark-Wahnefried W.

Curr Biomark Find. 2014 Jan 15;2014(4):1-7.

48.

Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups.

Libby E, Garcia D, Quintana D, Fekrazad MH, Bauman J, Ebaid A, Hromas R, Rabinowitz I, Wiggins C.

Leuk Lymphoma. 2014 Dec;55(12):2850-7. doi: 10.3109/10428194.2014.897700. Epub 2014 May 9.

PMID:
24588734
49.

Eco-evolutionary feedback and the tuning of proto-developmental life cycles.

Libby E, Rainey PB.

PLoS One. 2013 Dec 18;8(12):e82274. doi: 10.1371/journal.pone.0082274. eCollection 2013.

50.

The contribution of private and public information in foraging by Australasian gannets.

Machovsky-Capuska GE, Hauber ME, Libby E, Amiot C, Raubenheimer D.

Anim Cogn. 2014 Jul;17(4):849-58. doi: 10.1007/s10071-013-0716-x. Epub 2013 Dec 14.

PMID:
24337907

Supplemental Content

Support Center